# Allogeneic Adoptive Immune Therapy for Advanced AIDS Patients

> **NCT04098770** · PHASE2 · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 240 (estimated)

## Conditions studied

- AIDS Patients

## Interventions

- **BIOLOGICAL:** Allogeneic Adoptive Immune Therapy

## Key facts

- **NCT ID:** NCT04098770
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-11
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04098770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04098770, "Allogeneic Adoptive Immune Therapy for Advanced AIDS Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04098770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*